Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects.
about
Controlled release systems containing solid dispersions: strategies and mechanismsExemestane loaded self-microemulsifying drug delivery system (SMEDDS): development and optimizationPreparation and in vivo evaluation of SMEDDS (self-microemulsifying drug delivery system) containing fenofibrateA review on the strategies for oral delivery of proteins and peptides and their clinical perspectivesFlavonoid bioavailability and attempts for bioavailability enhancementNovel gastroretentive sustained-release tablet of tacrolimus based on self-microemulsifying mixture: in vitro evaluation and in vivo bioavailability test.Oral bioavailability enhancement of exemestane from self-microemulsifying drug delivery system (SMEDDS).Effect of lipolysis on drug release from self-microemulsifying drug delivery systems (SMEDDS) with different core/shell drug location.Dual approach utilizing self microemulsifying technique and novel P-gp inhibitor for effective delivery of taxanes.Preparation and evaluation of SEDDS and SMEDDS containing carvedilol.Lipid-based formulations for oral administration: opportunities for bioavailability enhancement and lipoprotein targeting of lipophilic drugs.Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin.Application of mixture experimental design to simvastatin apparent solubility predictions in the microemulsifion formed by self-microemulsifying.Oral bioavailability enhancement of acyclovir by self-microemulsifying drug delivery systems (SMEDDS).Preparation and evaluation of self-microemulsifying drug delivery system containing vinpocetine.Enhanced effect and mechanism of water-in-oil microemulsion as an oral delivery system of hydroxysafflor yellow AImprovement of colchicine oral bioavailability by incorporating eugenol in the nanoemulsion as an oil excipient and enhancerEnhanced stability and permeation potential of nanoemulsion containing sefsol-218 oil for topical delivery of amphotericin B.Nano composite emulsion for sustained drug release and improved bioavailability.Enhanced intestinal absorption of daidzein by borneol/menthol eutectic mixture and microemulsionFabrication of lipidic nanocarriers of loratadine for facilitated intestinal permeation using multivariate design approach.Development and optimization of a self-microemulsifying drug delivery system for atorvastatin calcium by using D-optimal mixture design.Enhanced dissolution and oral absorption of tacrolimus by supersaturable self-emulsifying drug delivery system.Lipid-Based Drug Delivery Systems.Interest of multifunctional lipid excipients: case of Gelucire 44/14.Combined use of phospholipid complexes and self-emulsifying microemulsions for improving the oral absorption of a BCS class IV compound, baicalin.Enhanced oral bioavailability of a sterol-loaded microemulsion formulation of Flammulina velutipes, a potential antitumor drug.Systematic development of self-emulsifying drug delivery systems of atorvastatin with improved bioavailability potential.In vitro and in vivo evaluation of a water-in-oil microemulsion system for enhanced peptide intestinal delivery.Optimized formulation of solid self-microemulsifying sirolimus delivery systemsDevelopment of self-nanoemulsifying drug delivery systems for the enhancement of solubility and oral bioavailability of fenofibrate, a poorly water-soluble drug.Lipid-based colloidal carriers for peptide and protein delivery--liposomes versus lipid nanoparticles.Self-microemulsifying drug delivery system for improved oral bioavailability of oleanolic acid: design and evaluation.Formulation development and bioavailability evaluation of a self-nanoemulsified drug delivery system of oleanolic acid.Evaluation of a nanoemulsion formulation strategy for oral bioavailability enhancement of danazol in rats and dogs.Impact of osmotically active excipients on bioavailability and bioequivalence of BCS class III drugs.Nanoemulsion improves the oral bioavailability of baicalin in rats: in vitro and in vivo evaluationHypoglycemic activity of a novel anthocyanin-rich formulation from lowbush blueberry, Vaccinium angustifolium AitonMultiple nanoemulsion system for an oral combinational delivery of oxaliplatin and 5-fluorouracil: preparation and in vivo evaluation.New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs.
P2860
Q24301733-D6C86531-CD89-4761-9C85-D3F46C56B07AQ24610012-1698D110-FD22-435A-9A28-E7E6D88780A1Q24647645-162F677B-CC74-42B2-94DE-EA2B0AE47520Q26744008-9F399D57-5F16-4B13-AC39-C264041D2EE1Q27009155-BBD20294-13C7-46D0-AACD-F099E625B32AQ33566190-9F806F15-F74D-4162-B555-A34749E6A7D4Q33573478-C44B072C-11FF-4B79-8838-E98ECAC46D4CQ33681221-5B800F99-10CF-4C08-BF60-1B5953B02F80Q34206944-D081F144-A2D2-40D1-8653-7A63559B4656Q34459102-44B2ADD8-22CE-404D-9C5B-6ABE47411E5EQ34470793-18DFD6B1-FB03-42A5-BA26-12B3FDD42B02Q34562249-F10B7708-1D24-40D5-A455-506F79766A59Q34692340-2C9F2BDA-E0B1-4D89-A679-5068A8316AC9Q34728544-23772799-A22D-4E30-97C5-26DB209FC08DQ34890252-35716B4E-D049-44C5-AC75-586FFEF9C61BQ35071621-3C100EBB-6F5F-4F3D-A4B6-92698D7C8252Q35090489-94DCD899-7468-4899-A11C-42D1B58DC7A3Q35127147-857ACA42-967E-4852-B820-2FBF1E81A3CDQ35154212-8534378A-1699-42BC-84DB-8EC89F6B381AQ35577248-C6DB5989-87B5-40FE-89A2-1AA029A5823AQ35667693-D0A71305-F870-4DC6-AED7-ACBE8496B665Q35717232-CD5D77FA-1175-4AAD-81AE-FA987AD369BCQ35981473-22A30BC9-13F7-411B-9E09-53853FF406DAQ36112195-B3AFEE6D-E2CB-4EA2-9E80-AEBC70BDA917Q36234508-13C445D5-3DE4-44E7-BC24-45CE3F1FA3CEQ36237489-460EA54D-F8FC-49FB-83A0-76A06E27B5E3Q36284469-DFE489DE-C81A-4C70-A922-5B64210328D4Q36482118-FAAC8400-226F-43A3-813D-C4F0F18AFCFFQ36502414-F22C89EC-BEF4-48ED-93DD-E495914926A5Q36805040-F13478AA-BB67-4A7B-B1F6-A12743D3E4CBQ37021478-0979FA06-6E60-4F56-9A15-CB43481C4DE1Q37059900-3087ADBC-7A2F-482A-B4B0-56C465E6AEDBQ37095744-388D47B0-29E2-41D3-8CB7-600877B1015DQ37146172-1F52A2CB-B147-4833-8BC2-225016D7CC53Q37171319-0B2B3F4E-79A4-4435-82ED-AFBE95A74F3CQ37207781-82889CC7-82BB-409B-8BCC-14EC17B404CBQ37225600-07D7E55C-631B-4360-AA03-DE35A7A9300CQ37283025-F40B3F7B-BE6F-4C3A-A8FB-1D3B361764CFQ37474599-BB4B2628-338E-4A70-A900-153B2D3004E9Q37805592-0A69F1CA-105C-4471-91E8-C95C978F5180
P2860
Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Lipid microemulsions for impro ...... and biopharmaceutical aspects.
@en
type
label
Lipid microemulsions for impro ...... and biopharmaceutical aspects.
@en
prefLabel
Lipid microemulsions for impro ...... and biopharmaceutical aspects.
@en
P356
P1476
Lipid microemulsions for impro ...... and biopharmaceutical aspects.
@en
P2093
P P Constantinides
P304
P356
10.1023/A:1016268311867
P577
1995-11-01T00:00:00Z